Skip to main content

Settlement News Before Abilify Bellwether Trials Begin

Settlement News Before Abilify Bellwether Trials Begin

Settlement News Before Abilify Bellwether Trials Begin

Introduction

Come June, the first set of Abilify bellwether trials will begin. Judge M. Casey Rodgers presiding over the centralized Abilify litigation is pushing for the parties involved in the first three cases to settle the dispute before the trials begin. The judge has appointed Settlement Master Cathy Yanni to take this settlement matter further and ordered the parties’ legal representatives to meet as per the order released on April 25.

The first trial is scheduled to begin on June 18, followed by the second trial on August 6, and the third trial on August 27 to be convened at the federal court in Pensacola.

The Abilify lawsuits were centralized in October 2016 as a part of MDL No. 2734 (In Re: Abilify Compulsive Behavior Products Liability Litigation) in the U.S. District Court for the Northern District of Florida, where more than 800 product liability lawsuits are pending against the defendant drugmakers Bristol-Myers Squibb and Otsuka Pharmaceuticals.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Attorneys Seek Reconsideration of Talc MDL Daubert Ruling

Categories: General

Plaintiffs’ attorneys are urging the U.S. District Judge overseeing the talcum powder lawsuit MDL to reconsider a recent decision for a second round…

Philips resolves DreamStation suits for $1.1B

Categories: Settlements

Dutch medical technology company Philips has finalized a $1.1 billion settlement in the United States to address lawsuits concerning faulty…

FDA OKs Generic OTC Naloxone Spray Approved by FDA

Categories: FDA Related

The FDA has granted approval for Amneal Pharmaceuticals to release a generic 4 mg naloxone hydrochloride nasal spray for over-the-counter (OTC) use, an announcement made in a press release.

Our Legal Drafting Services    
start @ $25 per hour.